Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00684580 · ClinicalTrials.gov registry record
Protocol For Collecting Data On Patients With Childhood Cancer
A clinical trial of Childhood Cancer, sponsored by St. Jude Children's Research Hospital.
- Recruiting
- Registry status
- 30,000
- Enrollment target
- 1
- Study location
NCT00684580: Recruiting study of Childhood Cancer, sponsored by St. Jude Children's Research Hospital.
NCT00684580 is a study of Childhood Cancer that is actively recruiting participants, run by St. Jude Children's Research Hospital. The registered enrollment target is 30,000 participants, above the 168-participant average among 23 other Childhood Cancer trials with a reported enrollment target (17757% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00684580, a study of Childhood Cancer, is actively recruiting participants, sponsored by St. Jude Children's Research Hospital.
- RECRUITING
- Registry status
- 30,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Progress in the development of curative therapy for pediatric malignancies has resulted in increasing numbers of long-term childhood cancer survivors. This protocol is a means to provide continuing review of outcome and late toxicity for all patients actively being treated and previously treated for childhood cancer at St. Jude Children's Research Hospital.
Conditions Studied
Interventions
- OTHER Data Collection
Study Locations (1)
Tennessee
- St. Jude Children's Research Hospital - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30,000 participants |
| Start Date | 2000-06-08 |
| Est. Completion | 2045-05 |
What NCT00684580 shows while recruiting
NCT00684580 is an observational study that tracks outcomes without assigning an intervention. Its 30,000 participants enrollment target places it among the larger protocols in the corpus, above the 168-participant average among 23 other Childhood Cancer trials with a reported enrollment target (17757% higher).
The record links to 1 condition, with Childhood Cancer appearing as the primary indexed condition, and to 1 intervention - of which Data Collection is the first listed.
NCT00684580 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT00684580 about?
NCT00684580 is a clinical study titled "Protocol For Collecting Data On Patients With Childhood Cancer". Progress in the development of curative therapy for pediatric malignancies has resulted in increasing numbers of long-term childhood cancer survivors. This protocol is a means to provide continuing review of outcome and late toxicity for all patients actively being treated and previously treated for...
What is the current status of trial NCT00684580?
This trial is currently recruiting. The enrollment target is 30,000 participants. The study started on 2000-06-08. Estimated completion is 2045-05.
What conditions does trial NCT00684580 study?
This clinical trial studies the following conditions: Childhood Cancer.
What interventions are being tested in trial NCT00684580?
The interventions under investigation include: Data Collection (OTHER).
Who is sponsoring clinical trial NCT00684580?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00684580 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Childhood Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00684580's enrollment target sits among peer trials
30,000 1st of 23 higher than 23 of 23 other Childhood Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Childhood Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Preparing for Life and Academics for Young Childhood Cancer Survivors
RECRUITING · NA
-
Assessment of Remote Approaches for Identification of Autonomic Dysfunction Among Survivors of Leukemia and Lymphoma
RECRUITING · NA
-
Patients At Risk for Sensory Screening (HPARSS) to Enhance Sensory Deficit Screening in Childhood Cancer Survivors
RECRUITING · NA
-
Light Therapy for Chemotherapy Induced Peripheral Neuropathy in Childhood Cancer Survivors
RECRUITING · NA
-
Mobile App to Help Survivors of Childhood Cancer Navigate Long-Term Follow-Up Care
RECRUITING · NA
-
Proof-of-Concept Testing of the Cardiovascular Health Equity Through Food (CHEF) Intervention in Childhood Cancer Survivors
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03053193 · 30,000 participants
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
- NCT03689595 · 30,000 participants
Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)
- NCT04834869 · 30,000 participants
COVID-19 Vaccines Safety Tracking (CoVaST)
- NCT05484804 · 30,000 participants · NA
Accountability for Care Through Undoing Racism & Equity for Moms
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI